<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Trans R Soc Trop Med Hyg</journal-id><journal-id journal-id-type="iso-abbrev">Trans. R. Soc. Trop. Med. Hyg</journal-id><journal-id journal-id-type="publisher-id">trstmh</journal-id><journal-title-group><journal-title>Transactions of the Royal Society of Tropical Medicine and Hygiene</journal-title></journal-title-group><issn pub-type="ppub">0035-9203</issn><issn pub-type="epub">1878-3503</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6364794</article-id><article-id pub-id-type="doi">10.1093/trstmh/try124</article-id><article-id pub-id-type="publisher-id">try124</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The double burden of diabetes and global infection in low and middle-income countries</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dunachie</surname><given-names>Susanna</given-names></name><xref ref-type="aff" rid="try124af1">1</xref><xref ref-type="aff" rid="try124af2">2</xref><xref ref-type="aff" rid="try124af3">3</xref><xref ref-type="corresp" rid="try124cor1"/><!--<email>susie.dunachie@ndm.ox.ac.uk</email>--></contrib><contrib contrib-type="author"><name><surname>Chamnan</surname><given-names>Parinya</given-names></name><xref ref-type="aff" rid="try124af4">4</xref></contrib></contrib-group><aff id="try124af1"><label>1</label>Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, 3rd Floor, 60th Anniversary Chalermprakiat Building, 420/6 Ratchawithi Rd., Ratchathewi District, Bangkok, Thailand</aff><aff id="try124af2"><label>2</label>Centre for Tropical Medicine and Global Health, University of Oxford, Nuffield Department of Medicine Research Building, University of Oxford, Old Road campus, Roosevelt Drie, Headington, Oxford, United Kingdom</aff><aff id="try124af3"><label>3</label>The Peter Medawar Building for Pathogen Research, University of Oxford, South Parks Road, Oxford, United Kingdom</aff><aff id="try124af4"><label>4</label>Cardiometabolic Research Group, Department of Social Medicine, Sunpasitthiprasong Hospital, Tambon Nai Mueang, Amphoe Mueang Ubon Ratchathani, Chang Wat Ubon Ratchathani, Thailand</aff><author-notes><corresp id="try124cor1">Corresponding author: Present address: Peter Medawar Building for Pathogen Research, University of Oxford, South Parks Road, Oxford OX1 3SY, United Kingdom; Tel.: +<phone>44(0)1865 281539</phone>; E-mail: <email>susie.dunachie@ndm.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2019</year></pub-date><pub-date pub-type="epub" iso-8601-date="2018-12-04"><day>04</day><month>12</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>12</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>113</volume><issue>2</issue><fpage>56</fpage><lpage>64</lpage><history><date date-type="received"><day>21</day><month>8</month><year>2018</year></date><date date-type="rev-recd"><day>23</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>02</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.</copyright-statement><copyright-year>2018</copyright-year><license license-type="cc-by" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="try124.pdf"/><abstract><title>Abstract</title><p>Four out of five people in the world with diabetes now live in low- and middle-income countries (LMIC), and the incidence of diabetes is accelerating in poorer communities. Diabetes increases susceptibility to infection and worsens outcomes for some of the world&#x02019;s major infectious diseases such as tuberculosis, melioidosis and dengue, but the relationship between diabetes and many neglected tropical diseases is yet to be accurately characterised. There is some evidence that chronic viral infections such as hepatitis B and HIV may predispose to the development of type 2 diabetes by chronic inflammatory and immunometabolic mechanisms. Helminth infections such as schistosomiasis may be protective against the development of diabetes, and this finding opens up new territory for discovery of novel therapeutics for the prevention and treatment of diabetes. A greater understanding of the impact of diabetes on risks and outcomes for infections causing significant diseases in LMIC is essential in order to develop vaccines and therapies for the growing number of people with diabetes at risk of infection, and to prioritise research agendas, public health interventions and policy. This review seeks to give an overview of the current international diabetes burden, the evidence for interactions between diabetes and infection, immune mechanisms for the interaction, and potential interventions to tackle the dual burden of diabetes and infection.</p></abstract><kwd-group kwd-group-type="keyword"><kwd>dengue</kwd><kwd> diabetes</kwd><kwd>global infection</kwd><kwd>melioidosis</kwd><kwd>tropical</kwd><kwd>tuberculosis</kwd></kwd-group><counts><page-count count="9"/></counts></article-meta></front><body><sec sec-type="intro" id="try124s1"><title>Introduction</title><p>There are now 336 million people with diabetes living in low- and middle-income countries (LMIC).<sup><xref rid="try124C1" ref-type="bibr">1</xref>,<xref rid="try124C2" ref-type="bibr">2</xref></sup> Diabetes increases susceptibility to infection and worsens outcomes for diseases such as tuberculosis (TB),<sup><xref rid="try124C3" ref-type="bibr">3</xref></sup> and the under-recognised tropical disease melioidosis.<sup><xref rid="try124C4" ref-type="bibr">4</xref>,<xref rid="try124C5" ref-type="bibr">5</xref></sup> Current international treatment guidelines for diabetes are based on research conducted in high-income countries focussed on preventing adverse cardiovascular outcomes and early death. There is a lack of evidence upon which to base guidelines for people living in LMIC, where there is an increased burden of infectious diseases compared with high income countries.</p></sec><sec id="try124s2"><title>Epidemiology of diabetes</title><p>Diabetes has traditionally been viewed as a &#x02018;disease of the wealthy&#x02019;, mostly found among elderly people in developed countries. Now, however, diabetes affects every strata of society, and has become a fast-growing problem in poorer communities. The Global Burden of Disease (GBD) study estimated there were 1.4 million deaths worldwide from diabetes in 2016,<sup><xref rid="try124C6" ref-type="bibr">6</xref></sup> representing a 31% increase from 2006. Of the estimated 425 million people with diabetes worldwide, four-fifths currently live in LMIC and increasing numbers of children and young adults have been diagnosed with the disease.<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup> This number is projected to increase to 629 million by 2045, and most of the rising burden will occur in LMIC (Figure <xref ref-type="fig" rid="try124F1">1</xref>). In addition, diabetes is more likely to be undiagnosed or poorly treated in LMIC.<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup></p><fig id="try124F1" orientation="portrait" position="float"><label>Figure 1.</label><caption><p>Predicted increased prevalence of diabetes from 2017 to 2045 by geographic region; AFR, sub-Saharan Africa; EUR, Europe; MENA, Middle East and North Africa; NAC, North America and the Caribbean; SACA, South and Central America; SEA, South East Asia including India; WP, Western Pacific including China, Indonesia and Australia. Reproduced with kind permission from the International Diabetes Federation World IDF Diabetes Atlas 2017<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup>.</p></caption><graphic xlink:href="try124f01"/></fig><p>Data from the NCD Risk Factor Collaboration<sup><xref rid="try124C2" ref-type="bibr">2</xref></sup> show that age-standardised diabetes prevalence in adults has increased or remained unchanged since 1980 in every country.<sup><xref rid="try124C2" ref-type="bibr">2</xref></sup> Importantly, the burden of diabetes has increased faster in LMIC than in high-income countries.<sup><xref rid="try124C2" ref-type="bibr">2</xref></sup> This rising prevalence of diabetes in LMIC is believed to be associated with many factors, including ageing populations, urbanisation, cultural and social changes, dietary changes, physical inactivity, changes in diagnostic criteria and screening practices, better treatment and survival, and increasing trends in overweight and obesity.</p><sec id="try124s2a"><title>Classification of diabetes</title><p>Table <xref rid="try124TB1" ref-type="table">1</xref> shows the current classification of diabetes by WHO and the American Diabetes Association (ADA),<sup><xref rid="try124C7" ref-type="bibr">7</xref>,<xref rid="try124C8" ref-type="bibr">8</xref></sup> which includes four clinical and aetiological classes: type 1 diabetes (T1DM), type 2 diabetes (T2DM), gestational diabetes mellitus, and other specific types of diabetes due to other causes. T1DM is caused by an autoimmune reaction which destroys the insulin-producing beta cells in the islets of the pancreas, leading to no or low production of insulin. T2DM is the most common type of diabetes, accounting for approximately 90% of all cases of diabetes worldwide.<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup> It is characterised by an inadequate production of insulin and an inability of the body to respond fully to insulin, defined as insulin resistance. It is important to note that assigning a type of diabetes to an individual is often reliant on the circumstances present and additional testing at the time of diagnosis, and that many patients with diabetes do not easily fit into a single class. In LMIC, it is often unknown which type of diabetes a person has, and therefore this review will use the general term &#x02018;diabetes&#x02019;, but &#x0003e;90% of patients with diabetes in LMIC are believed to have T2DM.<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup><table-wrap id="try124TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Aetiological classification of diabetes mellitus, adapted from WHO<sup><xref rid="try124C7" ref-type="bibr">7</xref></sup> and the American Diabetes Association<sup><xref rid="try124C8" ref-type="bibr">8</xref></sup></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Type</th><th rowspan="1" colspan="1">Pathophysiology</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Type 1<list list-type="simple"><list-item><p>&#x02003;&#x025aa; Autoimmune</p></list-item><list-item><p>&#x02003;&#x025aa; Idiopathic</p></list-item></list></td><td rowspan="1" colspan="1">Results from &#x003b2;-cell destruction, usually leading to absolute insulin deficiency</td></tr><tr><td rowspan="1" colspan="1">Type 2<list list-type="simple"><list-item><p>&#x02003;&#x025aa; Predominantly insulin resistance</p></list-item><list-item><p>&#x02003;&#x025aa; Predominantly insulin secretory defects</p></list-item></list></td><td rowspan="1" colspan="1">May range from predominantly insulin resistance with relative insulin deficiency to a predominantly secretory defect with or without insulin resistance</td></tr><tr><td rowspan="1" colspan="1">Other specific types</td><td rowspan="1" colspan="1">Results from other causes including genetic defects in &#x003b2;-cell function; genetic defects in insulin action; diseases of the exocrine pancreas; endocrinopathies; drug or chemical induced; infections</td></tr><tr><td rowspan="1" colspan="1">Gestational diabetes</td><td rowspan="1" colspan="1">Diagnosed during pregnancy (encompasses gestational impaired glucose tolerance and gestational diabetes mellitus)</td></tr></tbody></table></table-wrap></p></sec><sec id="try124s2b"><title>Risk factors of diabetes</title><p>Table <xref rid="try124TB2" ref-type="table">2</xref> summarises the modifiable and non-modifiable risk factors for T2DM, which is a disease caused by a complex interplay between genetic and environmental factors.<sup><xref rid="try124C9" ref-type="bibr">9</xref></sup> The rapid increase in the prevalence of diabetes over recent decades suggests that environmental and lifestyle factors might play an increasingly important role in the development of the disease.
<table-wrap id="try124TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Modifiable and non-modifiable risk factors for type 2 diabetes (adapted from the International Diabetes Federation: a consensus on type 2 diabetes prevention)<sup><xref rid="try124C9" ref-type="bibr">9</xref></sup></p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Modifiable risk factors</th><th rowspan="1" colspan="1">Non-modifiable risk factors</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Overweight and obesity (central and total)</td><td rowspan="1" colspan="1">Age</td></tr><tr><td rowspan="1" colspan="1">Sedentary lifestyle</td><td rowspan="1" colspan="1">Sex</td></tr><tr><td rowspan="1" colspan="1">Adverse diet/dietary factors</td><td rowspan="1" colspan="1">Ethnicity</td></tr><tr><td rowspan="1" colspan="1">Smoking</td><td rowspan="1" colspan="1">Family history of type 2 diabetes</td></tr><tr><td rowspan="1" colspan="1">Intrauterine environment</td><td rowspan="1" colspan="1">History of gestational diabetes</td></tr><tr><td rowspan="1" colspan="1">Hypertension/use of antihypertensive medication</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Serum cholesterol</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Triglycerides</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Previously identified glucose intolerance</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></p></sec></sec><sec id="try124s3"><title>Diabetes and specific infections</title><p>It is generally recognised that people with diabetes are at increased risk of infection and worse outcomes,<sup><xref rid="try124C10" ref-type="bibr">10</xref>,<xref rid="try124C11" ref-type="bibr">11</xref></sup> including diabetic foot infection, urinary tract infections (especially from <italic>Escherichia coli)</italic>, <italic>Streptococcal</italic> pneumonia, cellulitis (of which <italic>Streptococcal</italic> species are a common cause), <italic>Candida</italic> and <italic>Mucor</italic> invasive fungal infections, skin and surgical site infections. This review will focus on the evidence for increased risk to pathogens of particular significance in LMIC, with the findings summarised in Box <xref rid="try124TB3" ref-type="table">1</xref><table-wrap id="try124TB3" orientation="portrait" position="float"><label>Box 1.</label><caption><p>Relationship between diabetes and susceptibility/increased disease severity for significant pathogens in low- and middle-income countries. See text for discussion of evidence.</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1">Established increased susceptibility/severity (several good quality studies)</th><th rowspan="1" colspan="1">Probable increased susceptibility/severity (some evidence)</th><th rowspan="1" colspan="1">Further evidence of interaction needed (single or conflicting reports, or lack of data)</th><th rowspan="1" colspan="1">Potential inverse interaction (single studies or more)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> (TB)</td><td rowspan="1" colspan="1"><italic>Mycobacterium leprae</italic> (leprosy)</td><td rowspan="1" colspan="1"><italic>Plasmodium falciparum</italic> (malaria)</td><td rowspan="1" colspan="1"><italic>Schistosoma</italic> species</td></tr><tr><td rowspan="1" colspan="1"><italic>Burkholderia pseudomallei</italic> (melioidosis)</td><td rowspan="1" colspan="1"><italic>Orientia tsutsugamushi</italic> (scrub typhus)</td><td rowspan="1" colspan="1">Zika</td><td rowspan="1" colspan="1"><italic>Strongyloides stercoralis</italic></td></tr><tr><td rowspan="1" colspan="1">Gram-negative bacteria, especially <italic>E. coli</italic> and <italic>Klebsiella</italic></td><td rowspan="1" colspan="1">Hepatitis B</td><td rowspan="1" colspan="1"><italic>Trypanosoma cruzi</italic></td><td rowspan="1" colspan="1"><italic>Wuchereria bancrofti</italic> (filariasis)</td></tr><tr><td rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic></td><td rowspan="1" colspan="1">Hepatitis C</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"><italic>Streptococcal</italic> species</td><td rowspan="1" colspan="1">Chikungunya</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Influenza</td><td rowspan="1" colspan="1">Varicella zoster</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Dengue</td><td rowspan="1" colspan="1">Human immunodeficiency virus</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">West Nile virus</td><td rowspan="1" colspan="1">Middle East Respiratory Syndrome (MERS)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"><italic>Leishmania</italic> species</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap>.</p><sec id="try124s3a"><title>Bacterial</title><p>Tuberculosis (TB) is a leading cause of disease and death worldwide, with an estimated 9 million cases of TB and 1.2 million deaths in 2017.<sup><xref rid="try124C6" ref-type="bibr">6</xref></sup> Diabetes is associated with a threefold increased risk of developing TB,<sup><xref rid="try124C3" ref-type="bibr">3</xref></sup> and increased risk of death or treatment failure in TB.<sup><xref rid="try124C12" ref-type="bibr">12</xref></sup> The GBD group reported diabetes accounting for 10.6% of the TB mortality in HIV-negative people.<sup><xref rid="try124C13" ref-type="bibr">13</xref></sup> In 2017, 790 000 cases of TB were attributable to diabetes,<sup><xref rid="try124C14" ref-type="bibr">14</xref></sup> and the absolute numbers of people with TB-diabetes co-morbidity is now similar to people with TB-HIV co-infection. More than half of the world&#x02019;s TB cases occur in five countries,<sup><xref rid="try124C15" ref-type="bibr">15</xref></sup> which have significant prevalence rates and total numbers of diabetes cases in adults aged 20&#x02013;79 years as follows: China (10.9%, 114 million), India (8.8%, 73 million), Indonesia (6.2%, 10 million), Philippines (6.2%, 3.7 million) and Pakistan (6.9%, 7.5 million).<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup> There is evidence that the presence of clinical TB disease drives stress hyperglycaemia, impacting on clinical outcomes and response to treatment.<sup><xref rid="try124C16" ref-type="bibr">16</xref></sup> As rates of diabetes continue to rise, and the TB epidemic continues, there is a pressing need for bidirectional screening in countries facing the double burden of TB and diabetes. Work in India has shown success at screening newly diagnosed TB cases for diabetes,<sup><xref rid="try124C17" ref-type="bibr">17</xref></sup> due to the availability of a simple screening blood test (HbA1c) and the use of existing systems established to screen TB cases for HIV. Screening people with diabetes for TB is more difficult due to the reliance on symptom questionnaires followed by chest x-ray. A blood test to diagnose TB in this setting is highly desirable, but current interferon gamma release assays (IGRAs) do not have sufficient sensitivity and specificity for this purpose. Diabetes is also associated with higher rates of <italic>Mycobacterium leprae</italic>.<sup><xref rid="try124C18" ref-type="bibr">18</xref>,<xref rid="try124C19" ref-type="bibr">19</xref></sup></p><p>The greatest increased risk for infection in people with diabetes is seen for the grossly under-recognised tropical disease melioidosis, which is caused by the Gram-negative bacterium <italic>Burkholderia pseudomallei</italic>. People with diabetes have a twelve-fold increased risk of melioidosis, and over half of all cases of melioidosis have diabetes.<sup><xref rid="try124C20" ref-type="bibr">20</xref></sup><italic>B. pseudomallei</italic> is an environmental saprophyte with a predilection for rice paddy fields, and melioidosis is typically seen in adults in middle age and above, often in rice-farming communities. A broad range of clinical presentations are seen, including pneumonia, acute sepsis with bacteraemia, abscess formation in any organ site, chronic subacute disease and latency.<sup><xref rid="try124C21" ref-type="bibr">21</xref>,<xref rid="try124C22" ref-type="bibr">22</xref></sup> Transmission of the bacterium to humans occurs via three routes: inhalational, cutaneous via skin abrasions and ingestion of contaminated drinking water.<sup><xref rid="try124C23" ref-type="bibr">23</xref></sup> The disease is commonly diagnosed in Southeast Asia and Northern Australia, but is now known to be present in 45 countries across tropical regions, with an estimated annual 165 000 cases and 89 000 deaths.<sup><xref rid="try124C24" ref-type="bibr">24</xref></sup> If rates of diabetes continue to rise as predicted, coupled with an increased reliance on older people for rice farming due to exodus of the younger generation to urban areas, then the burden of melioidosis will also rise.</p><p>Studies in high-income countries have shown that people with diabetes have high rates of infection from many common bacteria,<sup><xref rid="try124C25" ref-type="bibr">25</xref></sup> but some bacterial species are more frequently reported in association with diabetes. Diabetes is an established risk factor for invasive infection with <italic>Staphylococcus aureus</italic>.<sup><xref rid="try124C26" ref-type="bibr">26</xref></sup><italic>S. aureus</italic> is the commonest cause of tropical pyomyositis, an infection of skeletal muscle featuring intramuscular abscesses that is commonly seen in tropical regions and can account for 1&#x02013;4% of acute admissions.<sup><xref rid="try124C27" ref-type="bibr">27</xref></sup> Pyomyositis occurs less frequently in temperate zones, where diabetes is a known risk factor.<sup><xref rid="try124C28" ref-type="bibr">28</xref>,<xref rid="try124C29" ref-type="bibr">29</xref></sup> While diabetes has been reported in some case reports of tropical pyomyositis,<sup><xref rid="try124C30" ref-type="bibr">30</xref></sup> further research is needed to establish the association between diabetes and tropical pyomyositis. An association between diabetes and <italic>Salmonella</italic> infections has been reported. A retrospective review of 134 cases of <italic>Salmonella</italic> infection, including 38 cases of <italic>Salmonella</italic> Typhi, revealed that 34% of adults &#x0003e;50 years of age with <italic>Salmonella</italic> infections had diabetes.<sup><xref rid="try124C31" ref-type="bibr">31</xref></sup> Diabetes was associated with around a threefold increased risk of infection with <italic>S. enteritidi</italic>s following exposure in a US hospital outbreak.<sup><xref rid="try124C32" ref-type="bibr">32</xref></sup> People with diabetes have an increased risk of <italic>Klebsiella</italic> infections,<sup><xref rid="try124C33" ref-type="bibr">33</xref></sup> especially <italic>Klebsiella</italic> liver abscess in Asia.<sup><xref rid="try124C34" ref-type="bibr">34</xref>,<xref rid="try124C35" ref-type="bibr">35</xref></sup></p><p>Scrub typhus is a febrile illness caused by the Rickettsial group intracellular pathogen <italic>Orientia tsutsugamushi</italic>. Around a million cases a year occur in Asia,<sup><xref rid="try124C36" ref-type="bibr">36</xref></sup> and it is believed to exist in other tropical regions outside Asia.<sup><xref rid="try124C37" ref-type="bibr">37</xref></sup> Diabetes was an independent risk factor for more severe disease in a prospective study of eschar-positive scrub typhus.<sup><xref rid="try124C38" ref-type="bibr">38</xref></sup></p><p>It remains to be established why diabetes confers much greater susceptibility to, and worse outcomes for some bacteria than to others. Several of the bacteria most closely associated with diabetes, such as <italic>M. tuberculosis</italic> and <italic>B. pseudomallei</italic>, are predominantly intracellular bacteria. Impairments in phagocyte function and adaptive T cell immunity in diabetes may contribute to increased susceptibility to intracellular pathogens.</p><p>Diabetes is associated with antimicrobial resistance (AMR). Diabetes status is associated with increased rates of drug resistance in TB, including multidrug-resistant TB.<sup><xref rid="try124C39" ref-type="bibr">39</xref>,<xref rid="try124C40" ref-type="bibr">40</xref></sup> Besides TB, people with diabetes are over-represented in cohorts with multi-drug-resistant infections,<sup><xref rid="try124C41" ref-type="bibr">41</xref></sup> but there is a lack of evidence at present of higher rates of AMR in bacterial isolates from people with diabetes compared with isolates from non-diabetics. What is clear is that increasing rates of AMR will have a larger impact on people with diabetes, due to their higher risk of infection and increased need for healthcare exposure and interventions.</p></sec><sec id="try124s3b"><title>Viral</title><p>Dengue causes an estimated 101 million clinical cases per year and 37 800 deaths.<sup><xref rid="try124C6" ref-type="bibr">6</xref></sup> An association between diabetes and severe presentations of dengue is now broadly accepted.<sup><xref rid="try124C42" ref-type="bibr">42</xref></sup> However, studies are typically retrospective, often small in nature, and use varying definitions of severe dengue. In a meta-analysis of five case-control studies of acute dengue, diabetes was associated with an increased risk of a severe clinical presentation of dengue compared with either asymptomatic infection or non-severe acute dengue,<sup><xref rid="try124C43" ref-type="bibr">43</xref></sup> although given the limited data, the authors emphasised this was only suggestive of a link. This finding has been supported by further studies in Malaysia<sup><xref rid="try124C44" ref-type="bibr">44</xref></sup> and China.<sup><xref rid="try124C45" ref-type="bibr">45</xref></sup> A systematic review<sup><xref rid="try124C46" ref-type="bibr">46</xref></sup> to evaluate the contribution of non-communicable diseases (NCDs) to the development of severe dengue identified 16 relevant publications and gives a clear overview of this literature, but given the heterogeneity of the studies the authors concluded that the existing literature was inadequate for meaningful estimation of the impact of diabetes and other NCDs on dengue severity. The following year a Canadian group<sup><xref rid="try124C47" ref-type="bibr">47</xref></sup> reported a nearly three-fold higher prevalence of diabetes in 3236 patients in 22 studies with severe dengue than the prevalence of diabetes in 9067 subjects in 13 studies with non-severe dengue. The same analysis found hypertension, heart disease and obesity (conditions interrelated with diabetes) to be significantly more prevalent in severe dengue, and also reported a four-fold increased prevalence of diabetes in severe West Nile fever cases by the same methodology, supporting an earlier study<sup><xref rid="try124C48" ref-type="bibr">48</xref></sup>. The authors acknowledge the multiple limitations of this approach, including the heterogeneity of the studies and publication bias for studies included. There is clearly a need for further high-quality epidemiological studies to further define the association. There is some evidence that diabetes is associated with more severe disease in chikungunya disease,<sup><xref rid="try124C49" ref-type="bibr">49</xref></sup> but there is a current lack of data for analysing the relationship with Zika virus.</p><p>Other viral infections may be associated with diabetes. People with diabetes are an at-risk group for clinical illness, disease severity and death from influenza,<sup><xref rid="try124C50" ref-type="bibr">50</xref></sup> with a meta-analysis of 234 articles<sup><xref rid="try124C51" ref-type="bibr">51</xref></sup> showing diabetes to be a risk factor for death from pandemic influenza (predominantly H1N1), although there was a lack of high-quality cohort studies to demonstrate this in seasonal influenza. It is estimated that 260 million people are chronic carriers of the hepatitis B virus (HBV),<sup><xref rid="try124C52" ref-type="bibr">52</xref></sup> and HBV has recently been described as a neglected tropical disease.<sup><xref rid="try124C53" ref-type="bibr">53</xref></sup> A number of studies have shown a higher prevalence of HBV in people with diabetes,<sup><xref rid="try124C54" ref-type="bibr">54</xref>&#x02013;<xref rid="try124C56" ref-type="bibr">56</xref></sup> and people with chronic HBV are reported to have an increased risk of developing diabetes,<sup><xref rid="try124C57" ref-type="bibr">57</xref></sup> although this has not been demonstrated to date in sub-Saharan Africa.<sup><xref rid="try124C58" ref-type="bibr">58</xref>,<xref rid="try124C59" ref-type="bibr">59</xref></sup> In addition, diabetes is associated with disease progression of HBV,<sup><xref rid="try124C60" ref-type="bibr">60</xref>&#x02013;<xref rid="try124C62" ref-type="bibr">62</xref></sup> which has also been reported for hepatitis C.<sup><xref rid="try124C63" ref-type="bibr">63</xref></sup> Varicella zoster virus (VZV) causes chickenpox as a primary infection which can reactivate as herpes-zoster (shingles), especially in older people. Diabetes is an established risk factor for shingles.<sup><xref rid="try124C64" ref-type="bibr">64</xref>,<xref rid="try124C65" ref-type="bibr">65</xref></sup> Diabetes is considered a risk factor for Middle East Respiratory Syndrome (MERS). A recent systematic review<sup><xref rid="try124C66" ref-type="bibr">66</xref></sup> identified 58 published works for analysis, with several reporting diabetes as a risk factor for infection and death, but meta-analysis to quantitate the increased risk of diabetes across the studies was not possible due to the small number of studies addressing this risk factor.</p><p>People living with HIV (PLHIV) who receive combined antiretroviral therapy (ART) now have excellent long-term survival, but increased rates of metabolic disorders such as impaired glucose tolerance, hyperlipidaemia and body morphological changes (lipodystrophy syndrome) have been reported.<sup><xref rid="try124C67" ref-type="bibr">67</xref></sup> Increased rates of insulin resistance in PLHIV could occur due to the pro-inflammatory effects of chronic viral infection, direct effects of ART, and also indirect effects of ART such as dyslipidaemia and body fat distribution changes. Although studies in high-income Western countries have shown inconsistent results as to whether HIV infection increases the risk of T2DM or merely represents earlier diagnosis in a closely monitored population,<sup><xref rid="try124C68" ref-type="bibr">68</xref></sup> there is evidence that HIV increases the risk of diabetes in Asian and African populations. A study in Taiwan suggested PLHIV to be as much as sixfold more likely to develop diabetes than the rest of the population,<sup><xref rid="try124C69" ref-type="bibr">69</xref></sup> and a recent Thai study of PLHIV showed diabetes developed at a younger age compared with the general population.<sup><xref rid="try124C70" ref-type="bibr">70</xref></sup> Increased rates of diabetes have also been reported in PLHIV in South Africa,<sup><xref rid="try124C71" ref-type="bibr">71</xref></sup> Tanzania<sup><xref rid="try124C72" ref-type="bibr">72</xref></sup> and Ethiopia.<sup><xref rid="try124C71" ref-type="bibr">71</xref></sup> Older ART drugs such as stavudine and zidovudine are known to increase the risk of metabolic syndrome and diabetes, and are used less now, so future studies may not confirm this relationship.</p></sec><sec id="try124s3c"><title>Parasitic</title><p>Malaria remains one of the world&#x02019;s largest causes of mortality from infectious diseases, with an estimated 213 million cases and 720 000 deaths per annum.<sup><xref rid="try124C6" ref-type="bibr">6</xref></sup> In 2010, researchers reported a 46% increased risk of malaria in people with diabetes<sup><xref rid="try124C73" ref-type="bibr">73</xref></sup> in a case-control study in an urban setting in Ghana. The malaria was predominantly <italic>P. falciparum</italic>, asymptomatic and diagnosed by PCR. The comparison of probability of malaria infection was made between patients with diabetes (n=675) and a control group (n=791) comprising patients attending hypertension clinics, patients attending other hospital clinics, and hospital staff. The groups were not matched in that the diabetes group were older by a mean of 7.6 years and had a socio-economic profile associated with greater poverty, and the adjusted odds ratio for diabetes as a risk factor for <italic>P. falciparum</italic> infection was just outside significance in a multivariate analysis adjusting for these parameters (adjusted OR 1.36, 95% CI 0.98&#x02013;1.90). This report is very interesting, but there have been no further published clinical studies addressing the relationship between diabetes and malaria. If diabetes increases the risk of malaria this would be of huge significance on a global scale. As India is a country with a high burden of both diabetes and <italic>P. vivax</italic> malaria,<sup><xref rid="try124C74" ref-type="bibr">74</xref></sup> one might expect evidence of a relationship between diabetes and vivax malaria to emerge from research in this region. Further prospective studies with well-matched cohorts, and research into the effect on outcomes for people with malaria is needed.</p><p>Diabetes has been linked to increased risk of cutaneous<sup><xref rid="try124C75" ref-type="bibr">75</xref>,<xref rid="try124C76" ref-type="bibr">76</xref></sup> and visceral leishmaniasis,<sup><xref rid="try124C77" ref-type="bibr">77</xref></sup> and diabetes and hyperglycaemia were more frequently reported in cardiomyopathy caused by <italic>Trypanosoma cruzi</italic> (Chagas disease) than in controls.<sup><xref rid="try124C78" ref-type="bibr">78</xref></sup> There are a lack of data on the relationship between diabetes and most neglected tropical diseases (reviewed<sup><xref rid="try124C79" ref-type="bibr">79</xref></sup>) and prospective studies of people with diabetes in tropical regions are needed to evaluate this.</p><p>Some interesting findings have been reported for a lower risk of diabetes following helminth infections including schistosomiasis, strongyloides and filariasis, as reviewed by Berbudi and colleagues.<sup><xref rid="try124C80" ref-type="bibr">80</xref></sup> The mechanism for such a protective effect could be by helminth infection inducing a shift towards type 2 (anti-inflammatory) immune responses, and reducing chronic low-grade inflammation. A mouse model<sup><xref rid="try124C81" ref-type="bibr">81</xref></sup> demonstrated greater insulin sensitivity following <italic>S. mansoni</italic> infection in mice fed a high-fat diet, with an increase in type 2 cytokines and the ratio of M2 to M1 macrophages in white adipose tissue. Further research is evaluating whether helminth-derived molecules could be developed as novel therapeutic approaches to diabetes and metabolic syndrome.<sup><xref rid="try124C82" ref-type="bibr">82</xref></sup> In addition, a prospective randomised-control trial of helminth eradiation by albendazole therapy in Indonesia<sup><xref rid="try124C83" ref-type="bibr">83</xref></sup> is underway evaluating the impact of helminth infections on insulin resistance.</p></sec></sec><sec id="try124s4"><title>Mechanisms of increased susceptibility to infection in diabetes</title><p>The mechanisms by which diabetes confers altered susceptibility to infections are likely to be via multiple effects on the human immune system.</p><sec id="try124s4a"><title>General and systemic effects of diabetes on the immune system</title><p>People with diabetes have altered skin flora, including increased colonisation with <italic>S. aureus</italic>.<sup><xref rid="try124C84" ref-type="bibr">84</xref></sup> Breaches in the skin&#x02019;s integrity as a physical barrier to infection occur more commonly in diabetes due to the impact of chronic hyperglycaemia on peripheral nerves and vascular supply. Diabetes and its treatment has an impact on the composition of the gut microbiome,<sup><xref rid="try124C85" ref-type="bibr">85</xref></sup> and the pivotal role of the gut microbiome in modulating human innate and adaptive responses via pathogen recognition receptor pathways and secretion of immunomodulatory molecules by gut bacteria is now emerging.<sup><xref rid="try124C86" ref-type="bibr">86</xref></sup> In vitro, mild hyperglycaemia may favour pathogen growth, and while the contribution of this to human susceptibility to infection is unknown, glycosuria favours urinary tract infections. In addition, hyperglycaemia has a number of immunosuppressive effects, including impairment of neutrophil degranulation, complement activation and phagocytosis.<sup><xref rid="try124C50" ref-type="bibr">50</xref></sup> Hyperglycaemia does not, however, appear to be a key mechanism for the increased susceptibility to TB.<sup><xref rid="try124C87" ref-type="bibr">87</xref></sup> Diabetes is associated with endothelial dysfunction, oxidative stress and chronic inflammation.<sup><xref rid="try124C88" ref-type="bibr">88</xref></sup> In infections like dengue, this may support a shift towards an excessive pro-inflammatory response, leading to the cytokine storm, shock, vasculopathy and coagulopathy that feature in severe dengue.<sup><xref rid="try124C47" ref-type="bibr">47</xref></sup> Finally, people with diabetes have higher rates of hospital admissions,<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup> which exposes them to hospital-acquired infections and the risk of AMR.</p><p>There is overlap between the spectrum of pathogens that people with diabetes have, notably increased susceptibility to such as <italic>S. aureus</italic> and invasive fungi, and the infections seen in chronic granulomatous disease (CGD),<sup><xref rid="try124C89" ref-type="bibr">89</xref></sup> which is congenital deficiency in phagocytic function. This suggests impairment of neutrophil and macrophage function in people with diabetes as a key mechanism of susceptibility. This is supported by studies showing impaired neutrophil migration, phagocytosis and intracellular killing in the host response to <italic>B. pseudomallei</italic> in people with diabetes.<sup><xref rid="try124C90" ref-type="bibr">90</xref></sup> However, people with CGD are not known to have increased susceptibility to viral infections, and therefore this impairment of phagocyte function is unlikely to be the only cause of increased susceptibility to infection in diabetes.</p></sec><sec id="try124s4b"><title>Antibody responses</title><p>The literature on humeral responses to infection in people with diabetes does not suggest that poor antibody response is a dominant mechanism for the increased susceptibility to infection seen in diabetes. Most studies support adequate induction of antibodies in response to licenced antibody-inducing vaccines in people with diabetes<sup><xref rid="try124C91" ref-type="bibr">91</xref>&#x02013;<xref rid="try124C93" ref-type="bibr">93</xref></sup>. Higher antibody responses to influenza vaccine were seen in a US study of elderly people with diabetes compared with elderly non-diabetic people,<sup><xref rid="try124C94" ref-type="bibr">94</xref></sup> and antibodies induced by natural exposure to melioidosis were higher in those with diabetes.<sup><xref rid="try124C95" ref-type="bibr">95</xref></sup> Such higher responses in diabetes could be due to chronic hyperactivation of the innate immune response in T2DM resulting in polyclonal B-cell stimulation and enhanced antibody production to stimuli.<sup><xref rid="try124C96" ref-type="bibr">96</xref></sup></p></sec><sec id="try124s4c"><title>Cellular responses</title><p>Beyond neutrophil changes, people with diabetes have alterations in the function of several cell types including macrophages, Natural Killer cells, CD4 T cells and CD8 T cells function.<sup><xref rid="try124C97" ref-type="bibr">97</xref></sup> T cell responses are known to be important in host defence against intracellular pathogens, with intracellular antigens presented to CD8 T cells via the MHC Class 1 antigen presentation pathway, and digested antigens from both extracellular and intracellular sources presented to CD4 T cells via the MHC Class 2 system. HIV results in reduction of CD4 T cells, and the huge increased risk of TB seen in advanced HIV demonstrates the importance of CD4 cells in defence against TB. There is evidence of impaired antigen-specific T cell responses in people with diabetes in response to early TB<sup><xref rid="try124C97" ref-type="bibr">97</xref></sup>, B. pseudomallei<sup><xref rid="try124C20" ref-type="bibr">20</xref></sup> and VZV<sup><xref rid="try124C98" ref-type="bibr">98</xref></sup>, although in established TB the cellular response appears to be higher in diabetes.<sup><xref rid="try124C97" ref-type="bibr">97</xref></sup> In addition, differences in the regulation and orchestration of the immune response are seen in dengue.<sup><xref rid="try124C99" ref-type="bibr">99</xref></sup></p><p>For further detailed discussion of immune mechanisms, the reader is referred to a number of excellent reviews of immune impairment in diabetes.<sup><xref rid="try124C97" ref-type="bibr">97</xref>,<xref rid="try124C100" ref-type="bibr">100</xref></sup> Overall, diabetes can impair the immune system at a systemic, cellular and molecular level, but it is the alteration of T cell function that is most amenable to boosting with targeted vaccination strategies.</p><p>Acute infection is known to lead to hyperglycaemia as a consequence of the stress-response activation of the hypothalamic-pituitary-adrenal axis to increase secretion of cortisol and other hormones which promote peripheral insulin resistance, alongside alteration of insulin-receptor signalling by pro-inflammatory cytokines (reviewed<sup><xref rid="try124C101" ref-type="bibr">101</xref></sup>). Sepsis-related hyperglycaemia may be a risk factor for future development of T2DM,<sup><xref rid="try124C101" ref-type="bibr">101</xref></sup> and stress hyperglycaemia induced by chronic infections such as TB may contribute to the global burden of diabetes.<sup><xref rid="try124C16" ref-type="bibr">16</xref></sup></p></sec></sec><sec id="try124s5"><title>Interventions</title><p>Concerted international efforts to stem the tide of advancing diabetes in LMIC are urgently required. Implementation of evidence-based approaches that are effective at both prevention and early intervention for diabetes are needed. Such approaches require behavioural changes in diet and physical inactivity, raising public awareness of diabetes, and convincing policy-makers and the public alike of the benefits of early diagnosis for disease reversal and management. One of the targets for the UN&#x02019;s Sustainable Development Goal 3 (Good Health and Well-being) is to reduce by one-third premature mortality from NCDs through prevention and treatment by 2030, with action on diabetes essential. Actions include implementation of National Diabetes programmes and extension of health promotion activities.<sup><xref rid="try124C1" ref-type="bibr">1</xref></sup></p><p>Tackling the interaction between diabetes and infection requires a greater understanding of the immune mechanisms underlying the altered susceptibility to infection seen in diabetes, and knowledge of how therapeutic management of diabetes impacts on risk of infection. It is likely that tight control of hyperglycaemia lowers the risk of infection, although this has yet to be comprehensively demonstrated in prospective studies. Current international treatment guidelines for T2DM are based on research conducted in high-income countries focussed on preventing adverse cardiovascular outcomes and early death. There is a lack of evidence on which to base guidelines for people living in LMIC, and choice of glucose-lowering therapy may impact on infection risk and outcomes. For example, there is emerging evidence for beneficial infection outcomes in people with diabetes taking metformin compared with other therapies,<sup><xref rid="try124C102" ref-type="bibr">102</xref>&#x02013;<xref rid="try124C104" ref-type="bibr">104</xref></sup> and glyburide/glibenclamide has been associated with anti-inflammatory properties and lower mortality in melioidosis.<sup><xref rid="try124C105" ref-type="bibr">105</xref></sup></p><p>Vaccination remains the cornerstone in controlling infectious diseases, and people with diabetes are prioritised as a high-risk group for vaccination against a range of pathogens including pneumococcus, influenza and VZV. Development of highly efficacious vaccines against intracellular infections such as TB, melioidosis and leishmaniasis, to which people with diabetes are at greater risk, is an important priority, and progress requires consideration of how to overcome the specific immune impairments seen in diabetes. Characterising the impact of diabetes on protective immunity is particularly important for melioidosis, where more than half of all cases occur in people with diabetes, and cost-effective implementation of a successful vaccine is likely to involve targeting this group.<sup><xref rid="try124C106" ref-type="bibr">106</xref></sup><italic>B. pseudomallei</italic> therefore represents an exemplar pathogen for defining the immune deficits in diabetes, and how to overcome them.</p></sec><sec sec-type="conclusions" id="try124s6"><title>Conclusions</title><p>The collision of diabetes and the world&#x02019;s global infections is a highly neglected area. More research to clearly define the epidemiology and illuminate successful interventions needs prioritising. The majority of the evidence for associations between diabetes and specific infections relies on the use of relatively small retrospective case-control studies, and meta-analysis approaches are limited by the heterogeneity of patient-level factors across studies. Diabetes is interrelated with obesity, hypertension and cardiovascular diseases that share similar risk factors and are each linked to adverse disease outcomes, rendering elucidation of the precise contribution of diabetes to excess morbidity and mortality difficult. The causal interaction between diabetes and infection rates and outcomes is also challenging. For some chronic viruses such as HBV and HIV, the association with diabetes may represent increased risk of diabetes by pathogenesis mechanisms resulting in insulin resistance related to chronic inflammation, rather than the other way around.</p><p>High-quality, large prospective epidemiology studies are needed to quantitate the problem, alongside randomised controlled trials of interventions to define optimal treatment strategies in diabetes. Raising awareness of the interaction of diabetes and infection with policy-makers, and ensuring the engagement of social scientists, health economists and the pharmaceutical industry in developing new strategies to fight this double burden in LMIC is vital.</p></sec></body><back><ack id="try124ack1"><p>
<bold>Authors' contributions:</bold> SD and PC wrote and reviewed the manuscript together.</p><p>
<bold>Acknowledgements:</bold> None.</p><p>
<bold>Funding:</bold> SD is grateful for the support of a Wellcome Trust Intermediate Clinical Fellowship award [WT100174/Z/12/Z]. Mahidol-Oxford Tropical Medicine Research Unit is supported by the Wellcome Trust.</p><p>
<bold>Competing interests:</bold> None declared.</p><p>
<bold>Ethical approval:</bold> Not required.</p></ack><ref-list><title>References</title><ref id="try124C1"><label>1</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>International Diabetes Federation</collab></person-group>
<source>IDF Diabetes Atlas</source>. <edition>8th ed</edition>
<publisher-loc>Brussels, Belgium</publisher-loc>: <publisher-name>International Diabetes Federation</publisher-name>; <year>2017</year>.</mixed-citation></ref><ref id="try124C2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>NCD Risk Factor Collaboration</collab></person-group>
<article-title>Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10027</issue>):<fpage>1513</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">27061677</pub-id></mixed-citation></ref><ref id="try124C3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jeon</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Murray</surname><given-names>MB</given-names></name></person-group>
<article-title>Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies</article-title>. <source>PLoS Med</source>. <year>2008</year>;<volume>5</volume>(<issue>7</issue>):<fpage>e152</fpage>.<pub-id pub-id-type="pmid">18630984</pub-id></mixed-citation></ref><ref id="try124C4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Suputtamongkol</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Dance</surname><given-names>DA</given-names></name>, <etal>et al</etal></person-group>
<article-title>The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand</article-title>. <source>Int J Epidemiol</source>. <year>1994</year>;<volume>23</volume>(<issue>5</issue>):<fpage>1082</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">7860160</pub-id></mixed-citation></ref><ref id="try124C5"><label>5</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Currie</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Jacups</surname><given-names>SP</given-names></name>, <name name-style="western"><surname>Cheng</surname><given-names>AC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia</article-title>. <source>Trop Med Int Health</source>. <year>2004</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1167</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">15548312</pub-id></mixed-citation></ref><ref id="try124C6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>GBD Causes of Death Collaborators</collab></person-group>
<article-title>Global, regional, and national age-sex specific mortality for 264 causes of death, 1980&#x02013;2016: a systematic analysis for the Global Burden of Disease Study 2016</article-title>. <source>Lancet</source>. <year>2017</year>;<volume>390</volume>(<issue>10100</issue>):<fpage>1151</fpage>&#x02013;<lpage>210</lpage>.<pub-id pub-id-type="pmid">28919116</pub-id></mixed-citation></ref><ref id="try124C7"><label>7</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>World Health Organization</collab></person-group>
<source>Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2006</year>.</mixed-citation></ref><ref id="try124C8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>American Diabetes A</collab></person-group>
<article-title>2. Classification and Diagnosis of Diabetes</article-title>. <source>Diabetes Care</source>. <year>2017</year>;<volume>40</volume>(<issue>Suppl 1</issue>):<fpage>S11</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">27979889</pub-id></mixed-citation></ref><ref id="try124C9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Alberti</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Zimmet</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Shaw</surname><given-names>J</given-names></name></person-group>
<article-title>International Diabetes Federation: a consensus on Type 2 diabetes prevention</article-title>. <source>Diabet Med</source>. <year>2007</year>;<volume>24</volume>(<issue>5</issue>):<fpage>451</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">17470191</pub-id></mixed-citation></ref><ref id="try124C10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Benfield</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Jensen</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Nordestgaard</surname><given-names>BG</given-names></name></person-group>
<article-title>Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome</article-title>. <source>Diabetologia</source>. <year>2007</year>;<volume>50</volume>(<issue>3</issue>):<fpage>549</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">17187246</pub-id></mixed-citation></ref><ref id="try124C11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Muller</surname><given-names>LMAJ</given-names></name>, <name name-style="western"><surname>Gorter</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Hak</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes Mellitus</article-title>. <source>Clin Infect Dis</source>. <year>2005</year>;<volume>41</volume>(<issue>3</issue>):<fpage>281</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">16007521</pub-id></mixed-citation></ref><ref id="try124C12"><label>12</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Dooley</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Golub</surname><given-names>JE</given-names></name>, <etal>et al</etal></person-group>
<article-title>Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis</article-title>. <source>Am J Trop Med Hyg</source>. <year>2009</year>;<volume>80</volume>(<issue>4</issue>):<fpage>634</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19346391</pub-id></mixed-citation></ref><ref id="try124C13"><label>13</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>GBD Tuberculosis Collaborators</collab></person-group>
<article-title>The global burden of tuberculosis: results from the Global Burden of Disease Study 2015</article-title>. <source>Lancet Infect Dis</source>. <year>2018</year>;<volume>18</volume>(<issue>3</issue>):<fpage>261</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">29223583</pub-id></mixed-citation></ref><ref id="try124C14"><label>14</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
<source>Global Tuberculosis Report 2018</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2018</year>.</mixed-citation></ref><ref id="try124C15"><label>15</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
<source>Global Tuberculosis Report 2017</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2017</year>.</mixed-citation></ref><ref id="try124C16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Magee</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Salindri</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Kyaw</surname><given-names>NTT</given-names></name>, <etal>et al</etal></person-group>
<article-title>Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications</article-title>. <source>Curr Diab Rep</source>. <year>2018</year>;<volume>18</volume>(<issue>9</issue>):<fpage>71</fpage>.<pub-id pub-id-type="pmid">30090969</pub-id></mixed-citation></ref><ref id="try124C17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Harries</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Satyanarayana</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Addressing diabetes mellitus as part of the strategy for ending TB</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <year>2016</year>;<volume>110</volume>(<issue>3</issue>):<fpage>173</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">26884497</pub-id></mixed-citation></ref><ref id="try124C18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Nigam</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Dayal</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Srivastava</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetic status in leprosy</article-title>. <source>Hansenol Int</source>. <year>1979</year>;<volume>4</volume>(<issue>1</issue>):<fpage>7</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">261975</pub-id></mixed-citation></ref><ref id="try124C19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Saraya</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Al-Fadhli</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Qasem</surname><given-names>JA</given-names></name></person-group>
<article-title>Diabetic status of patients with leprosy in Kuwait</article-title>. <source>J Infect Public Health</source>. <year>2012</year>;<volume>5</volume>(<issue>5</issue>):<fpage>360</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">23164565</pub-id></mixed-citation></ref><ref id="try124C20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jenjaroen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chumseng</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sumonwiriya</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>T-Cell Responses Are Associated with Survival in Acute Melioidosis Patients</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>10</issue>):<fpage>e0004152</fpage>.<pub-id pub-id-type="pmid">26495852</pub-id></mixed-citation></ref><ref id="try124C21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>NJ</given-names></name></person-group>
<article-title>Melioidosis</article-title>. <source>Lancet</source>. <year>2003</year>;<volume>361</volume>(<issue>9370</issue>):<fpage>1715</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">12767750</pub-id></mixed-citation></ref><ref id="try124C22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Wiersinga</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Currie</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Peacock</surname><given-names>SJ</given-names></name></person-group>
<article-title>Melioidosis</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>367</volume>(<issue>11</issue>):<fpage>1035</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">22970946</pub-id></mixed-citation></ref><ref id="try124C23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Limmathurotsakul</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kanoksil</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wuthiekanun</surname><given-names>V</given-names></name>, <etal>et al</etal></person-group>
<article-title>Activities of Daily Living Associated with Acquisition of Melioidosis in Northeast Thailand: A Matched Case-Control Study</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2013</year>;<volume>7</volume>(<issue>2</issue>):<fpage>3</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="try124C24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Limmathurotsakul</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Golding</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dance</surname><given-names>DAB</given-names></name>, <etal>et al</etal></person-group>
<article-title>Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis</article-title>. <source>Nat Microbiol</source>. <year>2016</year>;<volume>1</volume>(<issue>1</issue>):<fpage>15008</fpage>.</mixed-citation></ref><ref id="try124C25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bryan</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Reynolds</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Metzger</surname><given-names>WT</given-names></name></person-group>
<article-title>Bacteremia in diabetic patients: comparison of incidence and mortality with nondiabetic patients</article-title>. <source>Diabetes Care</source>. <year>1985</year>;<volume>8</volume>(<issue>3</issue>):<fpage>244</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">4006658</pub-id></mixed-citation></ref><ref id="try124C26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bassetti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Trecarichi</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Mesini</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia</article-title>. <source>Clin Microbiol Infect</source>. <year>2012</year>;<volume>18</volume>(<issue>9</issue>):<fpage>862</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21999245</pub-id></mixed-citation></ref><ref id="try124C27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chauhan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Varma</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Tropical pyomyositis (myositis tropicans): current perspective</article-title>. <source>Postgrad Med J</source>. <year>2004</year>;<volume>80</volume>(<issue>943</issue>):<fpage>267</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">15138315</pub-id></mixed-citation></ref><ref id="try124C28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Belsky</surname><given-names>DS</given-names></name>, <name name-style="western"><surname>Teates</surname><given-names>CD</given-names></name>, <name name-style="western"><surname>Hartman</surname><given-names>ML</given-names></name></person-group>
<article-title>Case report: diabetes mellitus as a predisposing factor in the development of pyomyositis</article-title>. <source>Am J Med Sci</source>. <year>1994</year>;<volume>308</volume>(<issue>4</issue>):<fpage>251</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">7942986</pub-id></mixed-citation></ref><ref id="try124C29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Crum</surname><given-names>NF</given-names></name></person-group>
<article-title>Bacterial pyomyositis in the United States</article-title>. <source>Am J Med</source>. <year>2004</year>;<volume>117</volume>(<issue>6</issue>):<fpage>420</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15380499</pub-id></mixed-citation></ref><ref id="try124C30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bhalla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>R</given-names></name>, <etal>et al</etal></person-group>
<article-title>Primary pyomyositis in North India: a clinical, microbiological, and outcome study</article-title>. <source>Korean J Intern Med</source>. <year>2018</year>;<volume>33</volume>(<issue>2</issue>):<fpage>417</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">29338140</pub-id></mixed-citation></ref><ref id="try124C31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Tseng</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>KJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>Salmonella infections: a retrospective 10-year analysis of 134 cases in a regional hospital in Taiwan</article-title>. <source>Scand J Infect Dis</source>. <year>1996</year>;<volume>28</volume>(<issue>2</issue>):<fpage>171</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">8792485</pub-id></mixed-citation></ref><ref id="try124C32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Telzak</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Greenberg</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Budnick</surname><given-names>LD</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes mellitus&#x02014;a newly described risk factor for infection from Salmonella enteritidis</article-title>. <source>J Infect Dis</source>. <year>1991</year>;<volume>164</volume>(<issue>3</issue>):<fpage>538</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">1869841</pub-id></mixed-citation></ref><ref id="try124C33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Leibovici</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Samra</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Konisberger</surname><given-names>H</given-names></name>, <etal>et al</etal></person-group>
<article-title>Bacteremia in adult diabetic patients</article-title>. <source>Diabetes Care</source>. <year>1991</year>;<volume>14</volume>(<issue>2</issue>):<fpage>89</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">2060428</pub-id></mixed-citation></ref><ref id="try124C34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>CC</given-names></name>, <name name-style="western"><surname>Yen</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Ho</surname><given-names>MW</given-names></name>, <etal>et al</etal></person-group>
<article-title>Comparison of pyogenic liver abscess caused by non-Klebsiella pneumoniae and Klebsiella pneumoniae</article-title>. <source>J Microbiol Immunol Infect</source>. <year>2004</year>;<volume>37</volume>(<issue>3</issue>):<fpage>176</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">15221038</pub-id></mixed-citation></ref><ref id="try124C35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>XX</given-names></name>, <name name-style="western"><surname>Tan</surname><given-names>B</given-names></name>, <etal>et al</etal></person-group>
<article-title>Distribution of common pathogens in patients with pyogenic liver abscess in China: a meta-analysis</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. <year>2016</year>;<volume>35</volume>(<issue>10</issue>):<fpage>1557</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">27401906</pub-id></mixed-citation></ref><ref id="try124C36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Paris</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Shelite</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Day</surname><given-names>NP</given-names></name>, <etal>et al</etal></person-group>
<article-title>Review article: Unresolved problems related to scrub typhus: A seriously neglected life-threatening disease</article-title>. <source>Am J Trop Med Hyg</source>. <year>2013</year>;<volume>89</volume>(<issue>2</issue>):<fpage>301</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">23926142</pub-id></mixed-citation></ref><ref id="try124C37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Paris</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>PN</given-names></name></person-group>
<article-title>A Systematic Review of Mortality from Untreated Scrub Typhus (Orientia tsutsugamushi)</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>8</issue>):<fpage>e0003971</fpage>.<pub-id pub-id-type="pmid">26274584</pub-id></mixed-citation></ref><ref id="try124C38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>CK</given-names></name>, <etal>et al</etal></person-group>
<article-title>Severity predictors in eschar-positive scrub typhus and role of serum osteopontin</article-title>. <source>Am J Trop Med Hyg</source>. <year>2011</year>;<volume>85</volume>(<issue>5</issue>):<fpage>924</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">22049051</pub-id></mixed-citation></ref><ref id="try124C39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>G&#x000f3;mez-G&#x000f3;mez</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Maga&#x000f1;a-Aquino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>L&#x000f3;pez-Meza</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes and Other Risk Factors for Multi-drug Resistant Tuberculosis in a Mexican Population with Pulmonary Tuberculosis: Case Control Study</article-title>. <source>Arch Med Res</source>. <year>2015</year>;<volume>46</volume>(<issue>2</issue>):<fpage>142</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">25704633</pub-id></mixed-citation></ref><ref id="try124C40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Perez-Navarro</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Restrepo</surname><given-names>BI</given-names></name>, <name name-style="western"><surname>Fuentes-Dominguez</surname><given-names>FJ</given-names></name>, <etal>et al</etal></person-group>
<article-title>The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes</article-title>. <source>Tuberculosis (Edinb)</source>. <year>2017</year>;<volume>103</volume>:<fpage>83</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">28237037</pub-id></mixed-citation></ref><ref id="try124C41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Guh</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Bulens</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Mu</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013</article-title>. <source>JAMA</source>. <year>2015</year>;<volume>314</volume>(<issue>14</issue>):<fpage>1479</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">26436831</pub-id></mixed-citation></ref><ref id="try124C42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mehta</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Hotez</surname><given-names>PJ</given-names></name></person-group>
<article-title>NTD and NCD Co-morbidities: The Example of Dengue Fever</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0004619</fpage>.<pub-id pub-id-type="pmid">27561091</pub-id></mixed-citation></ref><ref id="try124C43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Htun</surname><given-names>NS</given-names></name>, <name name-style="western"><surname>Odermatt</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Eze</surname><given-names>IC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Is diabetes a risk factor for a severe clinical presentation of dengue?&#x02014;review and meta-analysis</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e0003741</fpage>.<pub-id pub-id-type="pmid">25909658</pub-id></mixed-citation></ref><ref id="try124C44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mallhi</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Adnan</surname><given-names>AS</given-names></name>, <etal>et al</etal></person-group>
<article-title>Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study</article-title>. <source>BMC Infect Dis</source>. <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>399</fpage>.<pub-id pub-id-type="pmid">26423145</pub-id></mixed-citation></ref><ref id="try124C45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>[Analysis of clinical characteristic of 158 inpatients with dengue fever in Guangzhou area during the 2014 epidemic]</article-title>. <source>Zhonghua Wei Zhong Bing Ji Jiu Yi Xue</source>. <year>2015</year>;<volume>27</volume>(<issue>4</issue>):<fpage>300</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">25891462</pub-id></mixed-citation></ref><ref id="try124C46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Toledo</surname><given-names>J</given-names></name>, <name name-style="western"><surname>George</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Relevance of Non-communicable Comorbidities for the Development of the Severe Forms of Dengue: A Systematic Literature Review</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2016</year>;<volume>10</volume>(<issue>1</issue>):<fpage>e0004284</fpage>.<pub-id pub-id-type="pmid">26727113</pub-id></mixed-citation></ref><ref id="try124C47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Badawi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Velummailum</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ryoo</surname><given-names>SG</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prevalence of chronic comorbidities in dengue fever and West Nile virus: A systematic review and meta-analysis</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>7</issue>):<fpage>e0200200</fpage>.<pub-id pub-id-type="pmid">29990356</pub-id></mixed-citation></ref><ref id="try124C48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lindsey</surname><given-names>NP</given-names></name>, <name name-style="western"><surname>Staples</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lehman</surname><given-names>JA</given-names></name>, <etal>et al</etal></person-group>
<article-title>Medical risk factors for severe West Nile Virus disease, United States, 2008&#x02013;2010</article-title>. <source>Am J Trop Med Hyg</source>. <year>2012</year>;<volume>87</volume>(<issue>1</issue>):<fpage>179</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">22764311</pub-id></mixed-citation></ref><ref id="try124C49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Jean-Baptiste</surname><given-names>E</given-names></name>, <name name-style="western"><surname>von Oettingen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Larco</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Chikungunya Virus Infection and Diabetes Mellitus: A Double Negative Impact</article-title>. <source>Am J Trop Med Hyg</source>. <year>2016</year>;<volume>95</volume>(<issue>6</issue>):<fpage>1345</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">27729569</pub-id></mixed-citation></ref><ref id="try124C50"><label>50</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hulme</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Gallo</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Short</surname><given-names>KR</given-names></name></person-group>
<article-title>Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?</article-title><source>Front Microbiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>861</fpage>.<pub-id pub-id-type="pmid">28588558</pub-id></mixed-citation></ref><ref id="try124C51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mertz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Johnstone</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis</article-title>. <source>BMJ</source>. <year>2013</year>;<volume>347</volume>:<fpage>f5061</fpage>.<pub-id pub-id-type="pmid">23974637</pub-id></mixed-citation></ref><ref id="try124C52"><label>52</label><mixed-citation publication-type="other">
<person-group person-group-type="author"><collab>World Health Organisation</collab></person-group> WHO Hepatitis B Fact Sheet, <year>2017</year>.</mixed-citation></ref><ref id="try124C53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>O&#x02019;Hara</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>McNaughton</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Maponga</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hepatitis B virus infection as a neglected tropical disease</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2017</year>;<volume>11</volume>(<issue>10</issue>):<fpage>e0005842</fpage>.<pub-id pub-id-type="pmid">28981505</pub-id></mixed-citation></ref><ref id="try124C54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Serological and molecular analysis on the relationships between type 2 diabetes mellitus and hepatitis B virus infection</article-title>. <source>J Infect Dev Ctries</source>. <year>2016</year>;<volume>10</volume>(<issue>8</issue>):<fpage>837</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">27580329</pub-id></mixed-citation></ref><ref id="try124C55"><label>55</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Demir</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Serin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gokturk</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>The prevalence of occult hepatitis B virus infection in type 2 diabetes mellitus patients</article-title>. <source>Eur J Gastroenterol Hepatol</source>. <year>2008</year>;<volume>20</volume>(<issue>7</issue>):<fpage>668</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">18679070</pub-id></mixed-citation></ref><ref id="try124C56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Reilly</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Schillie</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus</article-title>. <source>J Diabetes Sci Technol</source>. <year>2012</year>;<volume>6</volume>(<issue>4</issue>):<fpage>858</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">22920812</pub-id></mixed-citation></ref><ref id="try124C57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Chang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ryu</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hepatitis B and C virus infection and diabetes mellitus: A cohort study</article-title>. <source>Sci Rep</source>. <year>2017</year>;<volume>7</volume>:<fpage>4606</fpage>.<pub-id pub-id-type="pmid">28676706</pub-id></mixed-citation></ref><ref id="try124C58"><label>58</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mekonnen</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Gebre-Selassie</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Fantaw</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prevalence of hepatitis B virus in patients with diabetes mellitus: a comparative cross sectional study at Woldiya General Hospital, Ethiopia</article-title>. <source>Pan Afr Med J</source>. <year>2014</year>;<volume>17</volume>:<fpage>40</fpage>.<pub-id pub-id-type="pmid">24932351</pub-id></mixed-citation></ref><ref id="try124C59"><label>59</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Onyekwere</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Anomneze</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Wali</surname><given-names>SS</given-names></name></person-group>
<article-title>Prevalence of serological markers of chronic hepatitis B virus infection in diabetics in the Lagos University Teaching Hospital, Lagos</article-title>. <source>Niger Postgrad Med J</source>. <year>2002</year>;<volume>9</volume>(<issue>3</issue>):<fpage>129</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">12501266</pub-id></mixed-citation></ref><ref id="try124C60"><label>60</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huo</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>PC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection</article-title>. <source>J Clin Gastroenterol</source>. <year>2000</year>;<volume>30</volume>(<issue>3</issue>):<fpage>250</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">10777182</pub-id></mixed-citation></ref><ref id="try124C61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>TC</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>SC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study</article-title>. <source>Clin Infect Dis</source>. <year>2013</year>;<volume>57</volume>(<issue>12</issue>):<fpage>1695</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">24051864</pub-id></mixed-citation></ref><ref id="try124C62"><label>62</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>YW</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>TC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study</article-title>. <source>Aliment Pharmacol Ther</source>. <year>2015</year>;<volume>41</volume>(<issue>11</issue>):<fpage>1200</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">25846548</pub-id></mixed-citation></ref><ref id="try124C63"><label>63</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Antonelli</surname><given-names>A</given-names></name></person-group>
<article-title>Hepatitis C virus infection and type 1 and type 2 diabetes mellitus</article-title>. <source>World J Diabetes</source>. <year>2014</year>;<volume>5</volume>(<issue>5</issue>):<fpage>586</fpage>.<pub-id pub-id-type="pmid">25317237</pub-id></mixed-citation></ref><ref id="try124C64"><label>64</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Kawai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Yawn</surname><given-names>BP</given-names></name></person-group>
<article-title>Risk Factors for Herpes Zoster: A Systematic Review and Meta-analysis</article-title>. <source>Mayo Clin Proc</source>. <year>2017</year>;<volume>92</volume>(<issue>12</issue>):<fpage>1806</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">29202939</pub-id></mixed-citation></ref><ref id="try124C65"><label>65</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Heymann</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Chodick</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Karpati</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Diabetes as a Risk Factor for Herpes Zoster Infection: Results of a Population-Based Study in Israel</article-title>. <source>Infection</source>. <year>2008</year>;<volume>36</volume>(<issue>3</issue>):<fpage>226</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">18454342</pub-id></mixed-citation></ref><ref id="try124C66"><label>66</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>J-E</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>MERS transmission and risk factors: a systematic review</article-title>. <source>BMC Public Health</source>. <year>2018</year>;<volume>18</volume>(<issue>1</issue>):<fpage>574</fpage>.<pub-id pub-id-type="pmid">29716568</pub-id></mixed-citation></ref><ref id="try124C67"><label>67</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Brar</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Shuter</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2007</year>;<volume>45</volume>(<issue>1</issue>):<fpage>66</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">17245229</pub-id></mixed-citation></ref><ref id="try124C68"><label>68</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Magee</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Dave</surname><given-names>JA</given-names></name>, <etal>et al</etal></person-group>
<article-title>HIV and Metabolic, Body, and Bone Disorders: What We Know From Low- and Middle-Income Countries</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2014</year>;<volume>67</volume>:<fpage>S27</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">25117959</pub-id></mixed-citation></ref><ref id="try124C69"><label>69</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lo</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Sheng</surname><given-names>WH</given-names></name>, <etal>et al</etal></person-group>
<article-title>Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case&#x02013;control study</article-title>. <source>HIV Med</source>. <year>2009</year>;<volume>10</volume>(<issue>5</issue>):<fpage>302</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19220492</pub-id></mixed-citation></ref><ref id="try124C70"><label>70</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Putcharoen</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Wattanachanya</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Sophonphan</surname><given-names>J</given-names></name>, <etal>et al</etal></person-group>
<article-title>New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes</article-title>. <source>AIDS</source>. <year>2017</year>;<volume>31</volume>(<issue>11</issue>):<fpage>1535</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">28398958</pub-id></mixed-citation></ref><ref id="try124C71"><label>71</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Abrahams</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dave</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Maartens</surname><given-names>G</given-names></name>, <etal>et al</etal></person-group>
<article-title>Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women</article-title>. <source>AIDS Res Ther</source>. <year>2015</year>;<volume>12</volume>:<fpage>24</fpage>.<pub-id pub-id-type="pmid">26251665</pub-id></mixed-citation></ref><ref id="try124C72"><label>72</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Maganga</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Smart</surname><given-names>LR</given-names></name>, <name name-style="western"><surname>Kalluvya</surname><given-names>S</given-names></name>, <etal>et al</etal></person-group>
<article-title>Glucose Metabolism Disorders, HIV and Antiretroviral Therapy among Tanzanian Adults</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>8</issue>):<fpage>e0134410</fpage>.<pub-id pub-id-type="pmid">26287742</pub-id></mixed-citation></ref><ref id="try124C73"><label>73</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Danquah</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Bedu-Addo</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mockenhaupt</surname><given-names>FP</given-names></name></person-group>
<article-title>Type 2 diabetes mellitus and increased risk for malaria infection</article-title>. <source>Emerg Infect Dis</source>. <year>2010</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1601</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">20875289</pub-id></mixed-citation></ref><ref id="try124C74"><label>74</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Anvikar</surname><given-names>AR</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dhariwal</surname><given-names>AC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Epidemiology of Plasmodium vivax Malaria in India</article-title>. <source>Am J Trop Med Hyg</source>. <year>2016</year>;<volume>95</volume>(<issue>6 Suppl</issue>):<fpage>108</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">27708188</pub-id></mixed-citation></ref><ref id="try124C75"><label>75</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Bamorovat</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sharifi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Aflatoonian</surname><given-names>MR</given-names></name>, <etal>et al</etal></person-group>
<article-title>Risk factors for anthroponotic cutaneous leishmaniasis in unresponsive and responsive patients in a major focus, southeast of Iran</article-title>. <source>PLoS One</source>. <year>2018</year>;<volume>13</volume>(<issue>2</issue>):<fpage>e0192236</fpage>.<pub-id pub-id-type="pmid">29415078</pub-id></mixed-citation></ref><ref id="try124C76"><label>76</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Sharquie</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Najim</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Hussein</surname><given-names>AK</given-names></name></person-group>
<article-title>Reinfestation in cutaneous leishmaniasis: a new look at predisposing conditions</article-title>. <source>Saudi Med J</source>. <year>2000</year>;<volume>21</volume>(<issue>5</issue>):<fpage>464</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">11500682</pub-id></mixed-citation></ref><ref id="try124C77"><label>77</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Weisser</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Khanlari</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Terracciano</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas?</article-title>
<source>Clin Microbiol Infect</source>. <year>2007</year>;<volume>13</volume>(<issue>8</issue>):<fpage>751</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">17610597</pub-id></mixed-citation></ref><ref id="try124C78"><label>78</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Cunha</surname><given-names>SFC</given-names></name>, <name name-style="western"><surname>Teixeira</surname><given-names>VPA</given-names></name><etal>et al</etal>,</person-group>
<article-title>Freq&#x000fc;&#x000ea;ncia de diabetes mellitus e hiperglicemia em mulheres chag&#x000e1;sicas e n&#x000e3;o-chag&#x000e1;sicas</article-title>. <source>Rev Soc Bras Med Trop</source>. <year>1999</year>;<volume>32</volume>:<fpage>489</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">10881081</pub-id></mixed-citation></ref><ref id="try124C79"><label>79</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>van Crevel</surname><given-names>R</given-names></name>, <name name-style="western"><surname>van de Vijver</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>DAJ</given-names></name></person-group>
<article-title>The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?</article-title><source>Lancet Diabetes Endocrinol</source>. <year>2017</year>;<volume>5</volume>(<issue>6</issue>):<fpage>457</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">27499355</pub-id></mixed-citation></ref><ref id="try124C80"><label>80</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Berbudi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ajendra</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wardani</surname><given-names>APF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes</article-title>. <source>Diabetes Metab Res Rev</source>. <year>2015</year>;<volume>32</volume>(<issue>3</issue>):<fpage>238</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">26119261</pub-id></mixed-citation></ref><ref id="try124C81"><label>81</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hussaarts</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Garc&#x000ed;a-Tard&#x000f3;n</surname><given-names>N</given-names></name>, <name name-style="western"><surname>van Beek</surname><given-names>L</given-names></name>, <etal>et al</etal></person-group>
<article-title>Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice</article-title>. <source>FASEB J</source>. <year>2015</year>;<volume>29</volume>(<issue>7</issue>):<fpage>3027</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">25852044</pub-id></mixed-citation></ref><ref id="try124C82"><label>82</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>C-L</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z-M</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>YR</given-names></name>, <etal>et al</etal></person-group>
<article-title>Schistosoma Infection and Schistosoma-Derived Products Modulate the Immune Responses Associated with Protection against Type 2 Diabetes</article-title>. <source>Front Immunol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1990</fpage>.<pub-id pub-id-type="pmid">29387059</pub-id></mixed-citation></ref><ref id="try124C83"><label>83</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Tahapary</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>de Ruiter</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>I</given-names></name>, <etal>et al</etal></person-group>
<article-title>Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia</article-title>. <source>BMC Infect Dis</source>. <year>2015</year>;<volume>15</volume>(<issue>1</issue>):<fpage>133</fpage>.<pub-id pub-id-type="pmid">25888525</pub-id></mixed-citation></ref><ref id="try124C84"><label>84</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Ahluwalia</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sood</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sood</surname><given-names>A</given-names></name>, <etal>et al</etal></person-group>
<article-title>Nasal colonization with Staphylococcus aureus in patients with diabetes mellitus [1]</article-title>. <source>Diabet Med</source>. <year>2000</year>;<volume>17</volume>(<issue>6</issue>):<fpage>487</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">10975221</pub-id></mixed-citation></ref><ref id="try124C85"><label>85</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Forslund</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hildebrand</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota</article-title>. <source>Nature</source>. <year>2015</year>;<volume>528</volume>:<fpage>262</fpage>.<pub-id pub-id-type="pmid">26633628</pub-id></mixed-citation></ref><ref id="try124C86"><label>86</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hooper</surname><given-names>LV</given-names></name>, <name name-style="western"><surname>Littman</surname><given-names>DR</given-names></name>, <name name-style="western"><surname>Macpherson</surname><given-names>AJ</given-names></name></person-group>
<article-title>Interactions Between the Microbiota and the Immune System</article-title>. <source>Science</source>. <year>2012</year>;<volume>336</volume>(<issue>6086</issue>):<fpage>1268</fpage>.<pub-id pub-id-type="pmid">22674334</pub-id></mixed-citation></ref><ref id="try124C87"><label>87</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lachmandas</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Vrieling</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wilson</surname><given-names>LG</given-names></name>, <etal>et al</etal></person-group>
<article-title>The effect of hyperglycaemia on in vitro cytokine production and macrophage infection with Mycobacterium tuberculosis</article-title>. <source>PLoS One</source>. <year>2015</year>;<volume>10</volume>(<issue>2</issue>):<fpage>e0117941</fpage>.<pub-id pub-id-type="pmid">25664765</pub-id></mixed-citation></ref><ref id="try124C88"><label>88</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Porter</surname><given-names>KE</given-names></name></person-group>
<article-title>Cellular and molecular mechanisms of endothelial dysfunction in diabetes</article-title>. <source>Diab Vasc Dis Res</source>. <year>2013</year>;<volume>10</volume>(<issue>6</issue>):<fpage>472</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">24002671</pub-id></mixed-citation></ref><ref id="try124C89"><label>89</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Roos</surname><given-names>D</given-names></name></person-group>
<article-title>Chronic granulomatous disease</article-title>. <source>Br Med Bull</source>. <year>2016</year>;<volume>118</volume>(<issue>1</issue>):<fpage>50</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">26983962</pub-id></mixed-citation></ref><ref id="try124C90"><label>90</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chanchamroen</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kewcharoenwong</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Susaengrat</surname><given-names>W</given-names></name>, <etal>et al</etal></person-group>
<article-title>Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects</article-title>. <source>Infect Immun</source>. <year>2009</year>;<volume>77</volume>(<issue>1</issue>):<fpage>456</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="pmid">18955471</pub-id></mixed-citation></ref><ref id="try124C91"><label>91</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Shaha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hoque</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Ahmed</surname><given-names>MF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Effects of Risk Factors on Anti-HBs Development in Hepatitis B Vaccinated and Nonvaccinated Populations</article-title>. <source>Viral Immunol</source>. <year>2015</year>;<volume>28</volume>(<issue>4</issue>):<fpage>217</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">25714135</pub-id></mixed-citation></ref><ref id="try124C92"><label>92</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Van Der Meeren</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Peterson</surname><given-names>JT</given-names></name>, <name name-style="western"><surname>Dionne</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus</article-title>. <source>Hum Vaccin Immunother</source>. <year>2016</year>;<volume>12</volume>(<issue>8</issue>):<fpage>2197</fpage>&#x02013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">27123743</pub-id></mixed-citation></ref><ref id="try124C93"><label>93</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yamasaki</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus</article-title>. <source>J Infect</source>. <year>2013</year>;<volume>67</volume>(<issue>3</issue>):<fpage>215</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">23603250</pub-id></mixed-citation></ref><ref id="try124C94"><label>94</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Frasca</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Diaz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>M</given-names></name>, <etal>et al</etal></person-group>
<article-title>Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine</article-title>. <source>Vaccine</source>. <year>2013</year>;<volume>31</volume>(<issue>35</issue>):<fpage>3603</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">23711934</pub-id></mixed-citation></ref><ref id="try124C95"><label>95</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Chaichana</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Jenjaroen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Amornchai</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Antibodies in Melioidosis: The Role of the Indirect Hemagglutination Assay in Evaluating Patients and Exposed Populations</article-title>. <source>Am J Trop Med Hyg</source>. <year>2018</year><pub-id pub-id-type="doi">10.4269/ajtmh.17-0998</pub-id>
<comment>[Epub ahead of print]</comment>.</mixed-citation></ref><ref id="try124C96"><label>96</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Zhai</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Qian</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Elevated B Cell Activation is Associated with Type 2 Diabetes Development in Obese Subjects</article-title>. <source>Cell Physiol Biochem</source>. <year>2016</year>;<volume>38</volume>(<issue>3</issue>):<fpage>1257</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">26982979</pub-id></mixed-citation></ref><ref id="try124C97"><label>97</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Hodgson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Morris</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bridson</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections</article-title>. <source>Immunology</source>. <year>2015</year>;<volume>144</volume>(<issue>2</issue>):<fpage>171</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">25262977</pub-id></mixed-citation></ref><ref id="try124C98"><label>98</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Okamoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hata</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sadaoka</surname><given-names>K</given-names></name>, <etal>et al</etal></person-group>
<article-title>Comparison of Varicella-Zoster Virus-Specific Immunity of Patients with Diabetes Mellitus and Healthy Individuals</article-title>. <source>J Infect Dis</source>. <year>2009</year>;<volume>200</volume>(<issue>10</issue>):<fpage>1606</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">19821719</pub-id></mixed-citation></ref><ref id="try124C99"><label>99</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>I-K</given-names></name>, <name name-style="western"><surname>Hsieh</surname><given-names>C-J</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>R-F</given-names></name>, <etal>et al</etal></person-group>
<article-title>Increased Production of Interleukin-4, Interleukin-10, and Granulocyte-Macrophage Colony-Stimulating Factor by Type 2 Diabetes&#x02019; Mononuclear Cells Infected with Dengue Virus, but Not Increased Intracellular Viral Multiplication</article-title>. <source>BioMed Res Int</source>. <year>2013</year>;<volume>2013</volume>:<fpage>7</fpage>.</mixed-citation></ref><ref id="try124C100"><label>100</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koh</surname><given-names>GC</given-names></name>, <name name-style="western"><surname>Peacock</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>van der Poll</surname><given-names>T</given-names></name>, <etal>et al</etal></person-group>
<article-title>The impact of diabetes on the pathogenesis of sepsis</article-title>. <source>Eur J Clin Microbiol Infect Dis</source>. <year>2012</year>;<volume>31</volume>(<issue>4</issue>):<fpage>379</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">21805196</pub-id></mixed-citation></ref><ref id="try124C101"><label>101</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Gornik</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Vujaklija</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Luki&#x00107;</surname><given-names>E</given-names></name>, <etal>et al</etal></person-group>
<article-title>Hyperglycemia in sepsis is a risk factor for development of type II diabetes</article-title>. <source>J Crit Care</source>. <year>2010</year>;<volume>25</volume>(<issue>2</issue>):<fpage>263</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19914033</pub-id></mixed-citation></ref><ref id="try124C102"><label>102</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Mor</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Petersen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Sorensen</surname><given-names>HT</given-names></name>, <etal>et al</etal></person-group>
<article-title>Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study</article-title>. <source>BMJ Open</source>. <year>2016</year>;<volume>6</volume>(<issue>8</issue>):<fpage>e011523</fpage>.</mixed-citation></ref><ref id="try124C103"><label>103</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Singhal</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jie</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name>, <etal>et al</etal></person-group>
<article-title>Metformin as adjunct antituberculosis therapy</article-title>. <source>Sci Transl Med</source>. <year>2014</year>;<volume>6</volume>(<issue>263</issue>):<fpage>263ra159</fpage>.</mixed-citation></ref><ref id="try124C104"><label>104</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Htun</surname><given-names>HL</given-names></name>, <name name-style="western"><surname>Yeo</surname><given-names>TW</given-names></name>, <name name-style="western"><surname>Tam</surname><given-names>CC</given-names></name>, <etal>et al</etal></person-group>
<article-title>Metformin Use and Severe Dengue in Diabetic Adults</article-title>. <source>Sci Rep</source>. <year>2018</year>;<volume>8</volume>(<issue>1</issue>):<fpage>3344</fpage>.<pub-id pub-id-type="pmid">29463812</pub-id></mixed-citation></ref><ref id="try124C105"><label>105</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Koh</surname><given-names>GCKW</given-names></name>, <name name-style="western"><surname>Maude</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>Schreiber</surname><given-names>MF</given-names></name>, <etal>et al</etal></person-group>
<article-title>Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis</article-title>. <source>Clin Infect Dis</source>. <year>2011</year>;<volume>52</volume>(<issue>6</issue>):<fpage>717</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">21293047</pub-id></mixed-citation></ref><ref id="try124C106"><label>106</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name name-style="western"><surname>Peacock</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>Limmathurotsakul</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Lubell</surname><given-names>Y</given-names></name>, <etal>et al</etal></person-group>
<article-title>Melioidosis vaccines: A systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2012</year>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref></ref-list></back></article>